Crossmark

Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy

Crossref DOI link: https://doi.org/10.1186/s12885-018-4240-x

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Chaobin

Mao, Yize

Wang, Jun

Duan, Fangting

Lin, Xiaojun

Li, Shengping
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81171890, 81672390)

Major National Scientific Research Projects of China (2013CB910304)
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 28 December 2017

Accepted: 16 March 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board (IRB) of the Sun Yat-sen University Cancer Center. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from patients prior to treatment.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.